Correlation Between Lineage Cell and Icon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lineage Cell and Icon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lineage Cell and Icon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lineage Cell Therapeutics and Icon Group, you can compare the effects of market volatilities on Lineage Cell and Icon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lineage Cell with a short position of Icon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lineage Cell and Icon.

Diversification Opportunities for Lineage Cell and Icon

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Lineage and Icon is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Lineage Cell Therapeutics and Icon Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icon Group and Lineage Cell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lineage Cell Therapeutics are associated (or correlated) with Icon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icon Group has no effect on the direction of Lineage Cell i.e., Lineage Cell and Icon go up and down completely randomly.

Pair Corralation between Lineage Cell and Icon

Assuming the 90 days trading horizon Lineage Cell Therapeutics is expected to generate 2.45 times more return on investment than Icon. However, Lineage Cell is 2.45 times more volatile than Icon Group. It trades about 0.2 of its potential returns per unit of risk. Icon Group is currently generating about 0.05 per unit of risk. If you would invest  17,140  in Lineage Cell Therapeutics on April 25, 2025 and sell it today you would earn a total of  15,660  from holding Lineage Cell Therapeutics or generate 91.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Lineage Cell Therapeutics  vs.  Icon Group

 Performance 
       Timeline  
Lineage Cell Therapeutics 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Lineage Cell Therapeutics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Lineage Cell sustained solid returns over the last few months and may actually be approaching a breakup point.
Icon Group 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Icon Group are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Icon may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Lineage Cell and Icon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lineage Cell and Icon

The main advantage of trading using opposite Lineage Cell and Icon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lineage Cell position performs unexpectedly, Icon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icon will offset losses from the drop in Icon's long position.
The idea behind Lineage Cell Therapeutics and Icon Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals